Tu sei qui
Socio Soci Corrispondenti
Anno di nomina: 2004
Email: carlo.patrono [@] unicatt.it
Data di nascita: 1/9/1944
già Prof. Ord. di Farmacologia nell'Università Cattolica del Sacro Cuore.
Carlo Patrono received his M.D. degree from the Catholic University School of Medicine (UCSC) in Rome, Italy, and trained as a Postdoctoral Fellow at Mount Sinai School of Medicine in New York with the late Solomon Berson and Nobel Laureate Rosalyn Yalow. He is Adjunct Professor of Pharmacology at the UCSC and the Perelman School of Medicine of the University of Pennsylvania. Prof. Patrono’s main research interest is in the study of platelet activation and inhibition in atherothrombosis and colorectal cancer. His research has characterized the human pharmacology of aspirin as an inhibitor of platelet thromboxane production and provided the basis for the development of low-dose aspirin as an antithrombotic agent. Moreover, Prof. Patrono contributed to characterizing the human pharmacology of cyclooxygenase-2 inhibitors and evaluating their cardiovascular effects in different clinical settings.
He is a Section Editor of the Journal of the American College of Cardiology and Associate Editor of the European Heart Journal.
He is a member of the scientific advisory boards of the William Harvey Research Institute of the University of London and the International Aspirin Foundation.
He has been elected to membership in scientific societies and academies, including the Association of American Physicians, the Royal College of Physicians, the European Society of Cardiology, the Academia Europaea and the Accademia Nazionale dei Lincei.
He has received the Alexander B. Gutman award from the Mount Sinai School of Medicine, the Distinguished Award in Neuroscience from the Louisiana State University, the 1998 International Aspirin® Award from Bayer AG, the 2007 John Vane Award from the William Harvey Research Institute, the 2011 Outstanding Achievement Award of the Eicosanoid Research Foundation, the 2013 Grand Prix Scientifique of the Institut de France, and the 2013 Lifetime Achievement Award of the European Association for Clinical Pharmacology and Therapeutics.